LEMAN BIOTECH

Startup

LEMAN BIOTECH

Description

Leman Biotech develops next-generation metabolic cancer immunotherapies designed for promoting metabolic reprogramming of terminally exhausted T cells.

LEMAN BIOTECH

Address

CHINA

Contact

Description

Leman Biotech develops next-generation metabolic cancer immunotherapies designed for promoting metabolic reprogramming of terminally exhausted T cells.

Matchmaking

Connect with LEMAN BIOTECH

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways